0000899243-21-023597.txt : 20210614
0000899243-21-023597.hdr.sgml : 20210614
20210614170355
ACCESSION NUMBER: 0000899243-21-023597
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210610
FILED AS OF DATE: 20210614
DATE AS OF CHANGE: 20210614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Spiegel Robert J.
CENTRAL INDEX KEY: 0001492256
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39279
FILM NUMBER: 211015354
MAIL ADDRESS:
STREET 1: C/O GERON CORPORATION
STREET 2: 230 CONSTITUTION DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001797336
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823578375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: (857) 444-0553
MAIL ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-10
0
0001797336
Ayala Pharmaceuticals, Inc.
AYLA
0001492256
Spiegel Robert J.
OPPENHEIMER 4
REHOVOT
L3
7670104
ISRAEL
1
0
0
0
Stock Option (Right to Buy)
10.35
2021-06-10
4
A
0
6250
0.00
A
2031-06-09
Common Stock
6250
6250
D
This option vests and becomes exercisable on the earlier of (i) June 10, 2022 or (ii) one day prior to the Company's 2022 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.
/s/ Roni Mamluk, Ph.D., Attorney-in-Fact for Robert J. Spiegel, M.D.
2021-06-14